Comparative study: Exploring the Advantages of Tb-161 over Lu-177 in Targeted Radionuclide Therapy and the impact of Antagonist vs Agonist

Research output: Contribution to journalMeeting AbstractAcademic

10 Downloads (Pure)
Original languageEnglish
Article numberEP-0995
Pages (from-to)S830-S830
Number of pages1
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume51
DOIs
Publication statusPublished - Sept 2024
EventAnnual Congress of the European-Association-of-Nuclear-Medicine (EANM) - Hamburg, Germany
Duration: 19 Oct 202423 Oct 2024

Cite this